Day One Biopharmaceuticals, Inc. (DAWN)

CIK 1845337 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Day One Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2026SCHEDULE 13G/A0000902664-26-002547
May 14, 2026SCHEDULE 13G/A0001708269-26-000002
May 4, 202615-12G0001193125-26-202385
Apr 27, 2026SCHEDULE 13D/A0001193125-26-182591
Apr 27, 202640001193125-26-182440
Apr 23, 2026S-8 POS0001193125-26-172024
Apr 23, 202640001863107-26-000005
Apr 23, 202640001855298-26-000006
Apr 23, 202640001690773-26-000005
Apr 23, 202640001776351-26-000001
Apr 23, 202640001655962-26-000005
Apr 23, 2026SC 14D9/A0001193125-26-171975
Apr 23, 2026POSASR0001193125-26-172004
Apr 23, 202640001580111-26-000001
Apr 23, 2026S-8 POS0001193125-26-172006
Apr 23, 202640001730229-26-000001
Apr 23, 202625-NSE0001354457-26-000366
Apr 23, 2026S-8 POS0001193125-26-172015
Apr 23, 202640001734755-26-000005
Apr 23, 20268-K0001193125-26-171997
Apr 23, 2026SC TO-T/A0001193125-26-171961
Apr 23, 202640001547959-26-000008
Apr 23, 2026S-8 POS0001193125-26-172020
Apr 23, 2026S-8 POS0001193125-26-172014
Apr 23, 202640001744507-26-000005